Latest articles from TalkMarkets - Financial markets analysis and insights
Updated: 1 hour 9 min ago
Trump Threatens To Close A New Bridge To Canada Unless US Gets Half The Bridge
President Trump is threatening to block the opening of the new Gordie Howe International Bridge unless the US receives a 50% ownership stake. This move adds fresh tension to US-Canada trade relations and infrastructure cost-sharing.
Financial Markets Report For Monday, Feb 9
In this video, Ira Epstein discusses the recent trends in the stock market, noting consecutive rallies and the potential for a Tuesday reversal based on historical patterns.
REE Prices Are Making New Highs
Rare Earth Element prices have surged to new highs, driven by tightening global supply and increasing demand from the tech and green energy sectors.
Things I Think I Think...
The S&P 500 tests 6,980 on low volume as China injects 3.2T Yuan for a liquidity gap. Focus shifts to the Fed’s "Gradual Print" and Scott Bessent’s warning of a China-driven gold "blowoff".
10 Red Flag Monthly Dividend Stocks With Unsafe Payouts
But while monthly dividend stocks are attractive on the surface, not all can sustain their payouts. Income investors should try to avoid dividend cuts or elimination as much as possible.
2026 Framework: Gold, Silver & Commodities — Stocks & Bonds Are Topping
U.S. stocks and government bonds are late-cycle, even new market highs could be a trap, sovereign debt is “not safe anymore”.
GBP/USD Tilts Bullish As Markets Barrel Toward Mid-Week NFP Print
GBP/USD gained another 0.55% on Monday, extending into a firm two-day recovery.
Liquidity Drains And Volatility Set The Stage For A Turnaround Tuesday
Stocks closed higher, with the S&P 500 up around 50 bps.
Squeeze Targets Exposed
The S&P 500 is pressing against 7,000 for the third time. It gapped lower at the open and rallied back throughout the session. The VIX dropped to 17.31 but never fully unwound from last week's spike.
Stocks And Precious Metals Charts - Stocks Were Wobbly
The Dollar took a major slip off the 98 handle down to 96.
Tech Tantrums
Concerns about growing capital expenditures on AI1 among tech giants have led to renewed bubble fears among market participants.
Up 955%, Is Applied Digital Just Hitting Its Stride?
Applied Digital has staged an extraordinary comeback, rocketing nearly 955% from its 52-week low of about $3.31 per share to recent closes around $35 per share.
Apple's FCF Margins Surge And Its Target Value Rises - What's The Best AAPL Stock Play?
Apple, Inc.'s revenue, free cash flow, and FCF margins surged in its latest quarter. This has pushed AAPL target prices higher. Two plays are attractive: short one-month out-of-the-money puts and buy longer-dated in-the-money calls.
Dow Marks Another Record Close; Nasdaq Enjoys Triple-Digit Pop
The Dow scored another record close on Monday, as investors look ahead to a busy week of economic data, including a delayed jobs report and the consumer price index (CPI) reading for January.
The King Of Cheap Debt Is Going To Unleash Another Round Of Inflation
One year into his second term, President Trump has increased the U.S.’s public debts by $2.32 trillion. At this pace, the U.S. will add $9.2 trillion in debt during President Trump’s 2nd term.
0.68%: Truflation Y/Y CPI Inflation Rate As Of 8 February 2026
If the true underlying y/y inflation rate is 0.68%, we must be coming close to deflation, which typically accompanies very slow growth in aggregate demand.
Americans Borrowed A Lot To Pay For Christmas 2025
The Debt Black Hole got a little bigger as U.S. consumer debt unexpectedly surged in December.
Momentum Investors Find Energy
Two of the best managed oil companies show that the Momentum trade has just begun to enter the oil patch.
Euro Rates May Need To Rise More To Attract Demand In 2026
Markets are facing a record amount of government bond supply in 2026 and our analysis suggests that yields may have to rise more to find sufficient demand.
Wild Week Of Rotation: Sector Performance 2026
Healthcare stocks show less volatility and better performance because of large cap biopharma.
